Holocene Advisors, LP Ventyx Biosciences, Inc. Transaction History

Holocene Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$29.8 - $40.3 $1.84 Million - $2.48 Million	61,607 Added 4.01%	1,598,691 $55.5 Million
Q2 2023 Aug 14, 2023	BUY	$28.53 - $39.55 $14.3 Million - $19.8 Million	500,571 Added 48.29%	1,537,084 $50.4 Million
Q1 2023 May 15, 2023	BUY	$29.51 - $46.65 $18.3 Million - $28.9 Million	619,278 Added 148.42%	1,036,513 $34.7 Million
Q4 2022 Feb 14, 2023	BUY	$24.16 - $36.38 $10.1 Million - $15.2 Million	417,235 New	417,235 $13.7 Million

125

53M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $105M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.